Solti F, Czakó E, Szatmáry L
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):26-9.
The electrophysiological characteristics and the antiarrhythmic indication areas of lorcainide were studied by using electrophysiological investigations and clinical studies in patients suffering from sustained arrhythmias. According to the data of the arrhythmia analyses (30 patients) the most important electrophysiological effects of lorcainide are: increase of the effective refractory period of the atria and ventricles; prolongation of the conduction time in the His bundle; prolongation of the refractory period and conduction of the accessory pathways. In the course of clinical studies (55 patients) lorcainide proved to be very effective in treating ventricular arrhythmias and preventing or disrupting ventricular tachyarrhythmic attacks. Lorcainide has a very promising antiarrhythmic effect in the suppression of tachyarrhythmias with accessory pathway conduction, too.
通过对持续性心律失常患者进行电生理研究和临床研究,探讨了劳卡尼的电生理特性和抗心律失常适应证范围。根据心律失常分析数据(30例患者),劳卡尼最重要的电生理效应为:增加心房和心室的有效不应期;延长希氏束传导时间;延长附加传导通路的不应期和传导时间。在临床研究过程中(55例患者),劳卡尼被证明对治疗室性心律失常以及预防或中断室性快速心律失常发作非常有效。劳卡尼在抑制伴有附加传导通路传导的快速心律失常方面也具有非常可观的抗心律失常作用。